News
2d
MedPage Today on MSNGLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA WarnsA potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...
Omada Health shares jumped after the company made its public-market debut, propelled by Americans’ renewed focus on how ...
True or False: Eating more pro-inflammatory foods was associated with worse overall survival in patients with stage III colon ...
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
GLP-1 drugs alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even ...
The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...
We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.
Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...
HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...
Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...
As consumers taking medications like Ozempic cut back on eating out, about 70% are spending more on cooking at home, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results